Cynata Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	68	34	53	22	52	72
Market Cap Growth	50.84%	-36.04%	136.00%	-56.47%	-28.71%	1.27%
Enterprise Value	66	23	42	6	25	47
Last Close Price	0.28	0.15	0.29	0.13	0.36	0.51
PS Ratio	40.40	17.98	22.88	13.57	6.64	46.80
PB Ratio	20.12	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	20.12	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	38.87	12.41	18.06	3.65	3.19	30.68
Net Debt / Equity Ratio	-0.76	-0.84	-0.86	-0.97	-0.99	-0.94
Net Debt / EBITDA Ratio	0.31	0.54	0.62	1.11	4.11	3.68
Asset Turnover	0.19	0.24	0.17	0.07	0.28	0.07
Quick Ratio	2.36	4.24	5.39	7.30	9.23	16.71
Current Ratio	2.49	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-112.99%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-62.05%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital Employed (ROCE)	-254.50%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-12.33%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-26.09%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%